Martis Capital is excited to have been named a Top 50 PE Firm in the Middle Market for 2022 for the second year in a row. Additionally, we are pleased to note that out of all the investment firms selected for this designation, Martis was the only healthcare exclusive private equity firm named among this year’s honorees.
Martis is honored to be included among this group of leading PE firms. This nomination reflects our commitment to being a transparent and thoughtful partner to middle-market healthcare companies.
Barry Uphoff, Founding and Managing Partner of Martis Capital, said, “Our goal at Martis Capital is to be the investor of choice for leading companies striving to improve patient outcomes, reduce costs and increase compliance across the healthcare ecosystem. As part of our investment approach, we strive to be a valuable resource for our portfolio companies and emphasize alignment within our relationships. We are thrilled to be included on the list of Top 50 PE Firms in The Middle Market for the second consecutive year.”
Martis did not pay a fee as part of the selection process. To read more about the Top 50 PE program and view a detailed list of winning firms, please visit TOP 50 PE Firms — GCI Publishing